Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.

Phase 1

• Conditions: Prevention of alveolar osteitis after third molar extraction; Therapeutic area: Diseases [C] - Mouth and tooth diseases [C07]; MedDRA version: 18.1Level: PTClassification code 10066995Term: Alveolar osteitisSystem Organ Class: 10021881 - Infections and infestations

• Registration Number: EUCTR2014-004682-24-EE
• Lead Sponsor: Institut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-03-09
• Last Update Posted: 23 May 2016

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 414

Inclusion Criteria

- Male or female, over 18 years old
- Subject needing to undergo extraction of one impacted mandibular third molar
- For woman of childbearing potential and for woman in menopausal period under hormonal substitution treatment, she must accept to plan the extraction of the impacted mandibular third molar only during the last week of the menstrual cycle
- Affiliated to a social security system, or is a beneficiary (if applicable in the national regulation)

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 374
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40

Exclusion Criteria

- Existence or history of parotid gland disorders
- Acute or history of recent acute pericoronitis at any tooth
- Extraction of more than 1 third molar in the same surgical procedure
- Subject at high risk of bacterial endocarditis (prosthetic heart valve, history of bacterial endocarditis, congenital cyanogenic heart disease)
- Coagulation or haemostatic disorder or use of anticoagulants
- Hypersensitivity to chlorhexidine or any of the excipients;
- Hypersensitivity to any anesthetic agent;
- Hypersensitivity to corticosteroids, analgesics including opioid drugs used for post-surgery pain relief
- Intake of systemic vasodilator or vasoconstrictor
- Intake of systemic or local (in the mouth) antibiotics within 7 days before Day 1 and/or any pre- or post-operative antibiotic prophylaxis planned to be prescribed during the study;
- Use of any antiseptic mouthwash within 7 days before Day -1
- Regular heavy smokers (more than 20 cigarettes per day)
- Is pregnant or in post-partum period or a nursing mother

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified